retatrutide obesity treatment RETATRUTIDE! The new magic for management Substack Series 3 of 6:

There exists an antagonism between the actions of AgRP (and NPY) and the melanocortins in controlling eating and body weight

Metformin was shown to display anti-cancer effects through its insulin-lowering activity, which may slow tumor proliferation in individuals with insulin resistance

This hyperglycemic state can induce non-enzymatic glycation of lipids and proteins, generating advanced glycation end-products (AGEs) [32]

Weeks 12 through 48 and beyond The longest clinical trial data we have extends to 48 weeks

Balancing GLP-1 Clinical Benefits with Financial Sustainability Pain Point : Plan sponsors are challenged to provide access to promising new medications while also controlling costs for both the plan and employees